Skip to main content
JAMA Network logoLink to JAMA Network
. 2022 Sep 30;5(9):e2233659. doi: 10.1001/jamanetworkopen.2022.33659

Examining Access to Primary Care for People With Opioid Use Disorder in Ontario, Canada

A Randomized Clinical Trial

Sheryl Spithoff 1,2,3,, Lana Mogic 1, Susan Hum 1, Rahim Moineddin 2, Christopher Meaney 2, Tara Kiran 2,4,5,6
PMCID: PMC9526081  PMID: 36178686

Key Points

Question

Are family physicians less likely to accept people with opioid use disorder as new patients than people with diabetes?

Findings

In this randomized clinical trial conducted in Ontario, Canada, assessing 383 family physicians, were almost 3 times less likely (4% vs 11%) to offer a new patient appointment to a prospective patient with opioid use disorder than those with diabetes.

Meaning

These findings suggest that physician discretion in accepting new patients contributes to poor primary care access for patients with opioid use disorder, indicating a need for health system changes.


This randomized clinical trial uses an audit design to compare rates at which family physician offices accept new patients with opioid use disorder vs new patients with diabetes in Ontario, Canada.

Abstract

Importance

People with opioid use disorder are less likely than others to have a primary care physician.

Objective

To determine if family physicians are less likely to accept people with opioid use disorder as new patients than people with diabetes.

Design, Setting, and Participants

This randomized clinical trial used an audit design to survey new patient intake at randomly selected family physicians in Ontario, Canada. Eligible physicians were independent practitioners allowed to prescribe opioids who were located in an office within 50 km of a population center greater than 20 000 people. A patient actor made unannounced telephone calls to family physicians asking for a new patient appointment. The data were analyzed in September 2021.

Intervention

In the first randomly assigned scenario, the patient actor played a role of patient with diabetes in treatment with an endocrinologist. In the second scenario, the patient actor played a role of a patient with opioid use disorder undergoing methadone treatment with an addiction physician.

Main Outcomes and Measures

Total offers of a new patient appointment; a secondary analysis compared the proportions of patients offered an appointment stratified by gender, population, model of care, and years in practice.

Results

Of a total 383 family physicians included in analysis, a greater proportion offered a new patient appointment to a patient with diabetes (21 of 185 physicians [11.4%]) than with opioid use disorder (8 of 198 physicians [4.0%]) (absolute difference, 7.4%; 95% CI, 2.0 to 12.6; P = .007). Physicians with more than 20 years in practice were almost 13 times less likely to offer an appointment to a patient with opioid use disorder compared with diabetes (1 of 108 physicians [0.9%] vs 10 of 84 physicians [11.9%]; absolute difference, 11.0; 95% CI, 3.8 to 18.1; P = .001). Women were almost 5 times less likely (3 of 111 physicians [2.7%] vs 14 of 114 physicians [12.3%]; absolute difference, 9.6%; 95% CI, 2.4 to 16.3; P = .007) to offer an appointment to a patient with opioid use disorder than with diabetes.

Conclusions and Relevance

In this randomized clinical trial, family physicians were less likely to offer a new patient appointment to a patient with opioid use disorder compared with a patient with diabetes. Potential health system solutions to this disparity include strengthening policies for accepting new patients, improved compensation, and clinician anti-oppression training.

Trial Registration

ClinicalTrials.gov Identifier: NCT05484609

Introduction

People with opioid use disorder (OUD) are a growing population in the US and Canada, as well as other in high-income countries.1 A large proportion have other chronic health conditions and some receive opioid agonist treatment (OAT).2,3,4,5,6 Access to high-quality primary care has the potential to improve care and health outcomes for this complex population.7,8,9,10 A recent study, set in Ontario, Canada, found that people with OUD who were enrolled with a primary care physician were more likely to have appropriate cancer screening and diabetes monitoring than those not enrolled.11 Similarly, an American study found that patients with OUD were more likely to receive appropriate preventative screenings when they received integrated addiction and primary care in a federally qualified health center.12

Despite these findings of improved health outcomes, people with OUD have poor access to primary care. In the Canadian study cited above, 43% of people in treatment for OUD were enrolled with a family physician, compared with 73% of matched controls.11 Another Canadian study found that among a cohort of people who use drugs, only 56% were engaged with primary care.13 Similarly, access to primary care for Americans who use substances, even among insured populations, is often poor.14,15 Research also indicates that finding a new physician may also be difficult for those with OUD. In a 2021 cohort study, people with OUD were significantly less likely to find a new family physician in the year after their enrollment with a previous physician was terminated.16

Research has identified some barriers to primary care for people who use substances. Patient factors, such as difficulty attending appointments, and system barriers, like transportation costs, impede access.17,18,19 Health care providers’ reluctance to care for this population may also play a role. In surveys, physicians report that they do not have the skills or time to care for people with addictions or who require prescribed opioids.20,21 Similarly, patients who use substances or have addictions reported having encountered physicians without appropriate knowledge and being refused acceptance into a practice.17,22,23,24 To date, however, studies have not determined how care decisions made by primary care physicians may factor into access to care for this population.

Our study objective, therefore, was to determine if family physicians are less likely to accept people with OUD as new patients than people with diabetes, by comparing the proportion of people with OUD offered a new patient appointment vs those with diabetes. In a secondary analysis, we investigated the impact of population size, physician gender, model of care25 and years in practice on the likelihood of being offered a new patient appointment.

Methods

Our study was conducted in Ontario, Canada’s largest province with a population of 15 million.26 Ontarians have publicly funded coverage for essential medical services including primary, emergency, and specialized care as well as for medical procedures and hospitalizations.27 About 91% of Ontarians report having a primary care provider, either a family physician or a nurse practitioner.28 Approximately 80% of Ontarians are formally enrolled to a physician practicing in an enrollment model.29 In enrollment models, physicians work in a group setting with shared after-hours responsibility and receive blended capitation and fee-for-service payments.29 About one-quarter of enrolled patients receive care in a team-based medical home (referred to as “family health teams”). Unlike other enrollment models, family health teams receive payments to hire additional staff such as nurse practitioners, counselors, and pharmacists.25,29

This study received ethics approval from Women’s College Hospital research ethics board, which waived informed consent by study participants. We did not register our study in advance because we did not have an experimental intervention (eg, drug, device, or behavioral intervention).

Study Design

We conducted a randomized clinical trial using a controlled audit study design30 with 2 parallel arms with 1:1 allocation (Supplement 1). A patient actor made unannounced telephone calls to randomly selected family physicians across Ontario asking for a new patient appointment. For our primary analyses, we compared an offer of a new patient appointment for a patient in treatment for diabetes vs a patient in treatment for OUD. For our prespecified secondary analysis, we compared proportions of patients offered an appointment for each scenario stratified by gender, population size, model of care, and years in practice.

Participants

Using publicly available data from the College of Physicians and Surgeons of Ontario (CPSO) website, we compiled a list of all Ontario physicians with a reported specialty in family medicine.31 The CPSO requires all practicing physicians in Ontario to submit updated practice information to the CPSO on a yearly basis. We also collected information on physician gender, years in practice, and practice postal code from the CPSO website. We used data from Statistics Canada on Canadian municipalities to determine the population of the physician’s primary practice setting based on the postal code. We determined whether the physician was part of a team using publicly available data from the Association of Family Health Teams in Ontario website.

Exclusions

Using information from the CPSO website, we excluded physicians with restricted practices as many of these physicians are not allowed to prescribe opioids as well as physicians not in independent practice (ie, medical residents or trainees). We only included 1 physician per practice address. A study statistician (C.M.) grouped family physicians by primary practice address and then selected, uniformly at random (with R version 4.0.4 [R Project for Statistical Computing]), 1 family physician who worked at the practice address, excluding the others. Using data from Statistics Canada,32 we also excluded physicians whose practice address was in a community with a population less than 10 000, unless they were close (ie, within 50 km) to a community with a population greater than 20 000. We excluded physicians in these communities because we hypothesized that the study scenario may not be plausible given that these settings may be too small to have a methadone clinic or an endocrinologist. At the time of making the phone calls, we excluded physicians who did not provide primary care, were no longer in practice, had a voicemail stating they were not accepting new patients, required an in person visit prior to accepting a new patient, required a health card number prior to accepting new patients, or only used Health Care Connect (a government service that requires a health card number) to accept new patients (Figure). Our patient actor could not provide a health card number (a unique, government-assigned number that enables access to publicly funded health services) without compromising their privacy. We also excluded physicians if we were unable to contact them, or leave a message, after 5 phone calls.

Figure. Flow Diagram of Trial Participation.

Figure.

Sample Size

Our team consensus was that a 10% difference in the proportion of new patient appointments offered to a patient with diabetes vs OUD would be clinically meaningful. In a similar study design, Olah et al30 found that 23.5% of those with diabetes were offered an appointment with a family physician in Ontario. Thus for our sample size calculation, we assumed that 23% of those with diabetes and 13% of those in treatment for OUD would be offered a new appointment. At 80% power, 5% type-1 error level, to detect a 10% difference in the proportion of new appointments offered between opioid (13%) and diabetes (23%) groups, we estimated we would need to contact 231 physicians with each scenario. However, previous studies using this approach found that up to one-third of physicians were excluded at the time of making the phone call (eg, the physician only provided walk-in services).30,33 Therefore, we estimated that we needed to contact 308 physicians in each arm. However, after making initial phone calls, we revised our estimate to 400 in each arm as only about 50% of the physicians we called met our inclusion criteria.

Sampling, Allocation, and Masking

Using the subset of eligible physicians, a study statistician (C.M.) sampled 799 family physicians, uniformly at random, and allocated them to the diabetes or OUD patient scenarios using simple randomization with a random Bernoulli sequence generator (Figure). Concealment of allocation was not possible, as the research assistant (L.M.) needed to know which scenario to implement during each phone call. The statisticians were masked to the scenario assignment when calculating the primary outcome. We made calls to the participants between June 11, 2021, and September 20, 2021. In total, 383 met our inclusion criteria and were included in the analysis. We excluded the other participants after allocation because we were unable to determine if these physicians met our inclusion criteria until after making the phone call and stating the scripted scenario (eTable 1 in Supplement 2).30

Intervention Scenarios

In the first scenario, the caller followed a script where they played the role of a patient with diabetes in treatment with an endocrinologist (eTable 1 in Supplement 2). In the second scenario, the caller played the role of a patient with OUD undergoing methadone treatment with an addiction physician. One member of the research team (L.M.) made all the phone calls. We phoned a physician’s practice up to 5 times over 6 weeks. If the office had voicemail, we left a message using the sample script, but continued to call up to 5 times. We accepted call-backs up to 6 weeks after the first phone call. If a physician’s practice offered an appointment, we canceled it the next day.

Outcomes

Our primary outcome measure was an offer of a new patient appointment with the physician we contacted, or with another physician or nurse practitioner at the same clinic. All other outcomes were considered negative including: placement on a waitlist; no call-back within 6 weeks; instructions to call back later at a date more than 6 weeks later (if less than 6 weeks, we called back); refusal to offer an appointment; suggestions to call another physician or nurse practitioner at the same clinic or another clinic; or no response to voicemail messages after six weeks. We concluded our study once we made up to 5 attempts to call these physicians.

Statistical Analysis

We used descriptive statistics (mean for continuous measures, frequency and percentages for nominal measures) to describe the sample. To assess the balance between the 2 groups, we used χ2 tests and Wilcoxon tests for categorical and continuous measures, respectively. To assess if our exclusions after allocation were balanced between the 2 groups, we used χ2 tests for categorical measures.

For our primary outcome, we used 2-sample χ2 tests to compare unconditional offers of a new patient appointment for a patient in treatment for diabetes with a patient in treatment for OUD. We also used multivariable logistic regression to model the likelihood of being offered a new appointment with a physician after controlling for our prespecified confounding factors: gender, rurality, years in practice and model of care.

For our prespecified secondary analysis, we performed a stratified analysis comparing proportions of patients offered an appointment for each scenario stratified by gender (men vs women), municipality population size (rural, population below 50 000 vs urban, population above 50,000), model of care (team-based vs not), and years in practice (more than 20 years vs less than 20 years). The absolute proportion differences 95% CIs and P values are reported. For our analyses, we considered a P < .05 to be statistically significant. Statistical analyses were conducted using SAS version 9.4 (SAS Institute).

Results

We included 383 physicians in our analysis. The reasons for exclusion after allocation were not statistically different between the 2 groups (eAppendix 2 in Supplement 2). Overall, 225 physicians (58.8%) were women, 40 (10.5%) practiced in a region with a population less than 50 000 people, and 37 (9.7%) practiced in a family health team (Table 1). Physicians had been in clinical practice for a mean (SD) average of 19.9 (10.1) years. Physician characteristics were not statistically different between the 2 groups (eAppendix 1 in Supplement 2).

Table 1. Characteristics of Physicians and Their Practices.

Characteristics Physicians, No. (%)
Overall (n = 383) Diabetes scenario (n = 185) OUD scenario (n = 198)
Gender
Women 225 (58.8) 114 (61.6) 111 (56.1)
Men 158 (41.2) 71 (38.4) 87 (43.9)
Office not near population centera 40 (10.5) 17 (9.2) 23 (11.7)
FHT model 37 (9.7) 22 (11.9) 15 (7.6)
Time in practice, mean (SD), y 19.9 (10.1) 18.8 (10.3) 20.9 (9.9)

Abbreviations: FHT, family health team; OUD, opioid use disorder.

a

Population centers defined as having more than 50 000 residents.

Primary Outcome

A greater proportion of physicians offered a new patient appointment to a caller with diabetes (21 of 185 physicians [11.4%]) than one in treatment for OUD (8 of 198 [4.0%]) (absolute difference, 7.4%; 95% CI, 2.0 to 12.6; P = .007) (Table 2). After controlling for gender, years in practice, practice location, and model of care, a caller presenting with diabetes had greater odds of being offered a new patient appointment (OR, 2.9; 95% CI, 1.3-6.8; P = .01).

Table 2. Stratified Secondary Analyses Rates of Offering a New Patient Appointment.

Subgroup No. of patients Physicians, No. (%) Absolute difference, % (95% CI) P value
Diabetes scenario (n=185) OUD scenario (n=198)
Total 383 21 (11.4) 8 (4.0) 7.4 (2.0 to 12.6) .007
Gender
Women 225 14/114 (12.3) 3/111 (2.7) 9.6 (2.8 to 16.3) .007
Men 158 7/71 (9.9) 5/87 (5.8) 4.1 (−4.4 to 12.6) .33
Population size
<50 000 40 0/17 2/23 (8.7) −8.7 (−20.2 to 2.8) .21
>50 000 340 21/167 (12.6) 6/173 (3.5) 9.1 (3.4 to 14.8) .002
Model of care
Team 37 3/22 (13.6) 0/15 13.6 (−0.7 to 28.0) .14
Not team 346 18/163 (11.0) 8/183 (4.4) 6.7 (1.0 to 12.3) .02
Time in practice
0-20 y 191 11/101 (10.9) 7/90 (7.8) 3.1 (−5.1 to 11.3) .46
21-36 y 192 10/84 (11.9) 1/108 (0.9) 11.0 (3.8 to 18.1) .001

Stratified Analysis

In the stratified analysis, we found that women (3 of 111 physicians [2.7%] vs 14 of 114 [12.3%]; absolute difference, 9.6%; 95% CI, 2.8 to 16.3; P = .007) as well as physicians practicing in larger centers (6 of 173 physicians [3.5%] vs 21 of 167 physicians [12.6%]; absolute difference, 9.1; CI, 3.4 to 14.8; P = .002), in a non-team model (8 of 183 physicians [4.4%] vs 118 of 163 physicians [1.0%]; absolute difference, 6.7; 95% CI, 1.0 to 12.3; P = .02) and physicians with more years in practice (1 of 108 physicians [0.9%] vs 10 of 84 physicians [11.9%]; absolute difference, 11.0; 95% CI, 3.8 to 18.1; P = .001) were less likely to offer a new patient appointment to a patient with OUD compared with a patient with diabetes (Table 2). Findings were not significant for men, physicians in more rural areas, in team-based practices, and with fewer years in practice.

Discussion

In this randomized clinical trial conducted in a setting with universal health coverage, we found that family physicians were almost 3 times less likely to offer a new patient appointment to a patient with OUD than diabetes. Our findings demonstrate that family physicians are reluctant to accept patients with OUD into their practices. Family physician discretion in accepting new patients, therefore, may be a major reason why patients with OUD take longer to find,16 and are less likely to have a family physician.11

Our study results align with findings from physician surveys. In a 2019 Canadian survey study,34 28% of physicians reported they would not accept patients requiring prescribed opioids into their practice. Similarly, an American study found that over 40% of clinics would not prescribe opioids to a simulated patient seeking a new patient appointment.35 Physicians report concerns that patients with OUD or who require prescribed opioids may be too complex as well as disruptive to their practice.20,21,36,37 Physicians also report that they lack the training, skills, and support necessary to provide appropriate care to this population.20,21 The reluctance to accept patients with OUD into a primary care practice may also be the result of physician attitudes toward people with addictions or who are prescribed opioids.23,38,39,40 Health care professionals report high levels of stigma, similar to the general public, toward these populations.20,36,41,42,43

Compensation models in Ontario may have played a role as well. Although all Canadians have access to universal health care, studies indicate that physicians are reluctant to accept complex, high-needs patients into their practices when they do not receive appropriate compensation.9 In Ontario, most physicians are eligible to bill special fee codes for the care of patients with diabetes.29,44 Although the province also provides special fee codes for the care of people with OUD, family physicians can only bill these codes if they are the primary provider of addiction care (including OAT such as methadone), a rarity in Ontario.45 Physicians practicing in Ontario, therefore, may be more inclined to accept a patient with diabetes into their practice believing they will be appropriately compensated for the complexity of care.

In a secondary stratified analysis, we found that physicians who had been in practice for more than 20 years were almost 13 times less likely to offer a new patient appointment to a caller with OUD than one with diabetes. Our finding aligns with the 2019 Canadian survey study where physicians with more years in practice were less likely to accept a new patient needing treatment with opioids than physicians who had been in practice for a shorter time.34 These findings may indicate changing attitudes and behaviors among newly trained physicians, reflecting emerging societal norms46,47 or improved medical education.48,49 We also found that female physicians were almost 5 times less likely to offer a new patient appointment to a patient with OUD than one with diabetes. This contradicts findings in the 2019 survey study where female physicians were more likely than male physicians to report accepting patients prescribed opioids into their practices.34 In a UK study, gender did not appear to influence physician willingness to prescribe opioids.50

Our small sample size for team-based models of care found no significant difference between patients with OUD and diabetes in the stratified analysis. Other studies have found that high-needs patients are less likely to be enrolled in highly-resourced, team-based medical models.9,16,51 Because physicians working in these models are funded based on age and sex, and not complexity, they may be incentivized to seek out healthy patients and avoid complicated ones.9,51 However, in the Canadian survey described above, physicians in team-based practices were more willing than others to report accepting patients prescribed opioids into their practices.34 Similarly, American physicians who were part of a large health plan with substantial infrastructure supports reported being less concerned about prescribing opioids than others.52

Our results suggest that policymakers should implement policies ensuring that all patients within a catchment area are automatically eligible for a primary care physician.53 Short of this solution, policymakers and regulatory bodies should enhance policies that reduce physician discretion in accepting new patients.51,54,55 To ensure physicians have the appropriate resources, compensation models should better reflect patient complexity.18,56 Equally important, policies should include measures to ensure high-quality care for complex and stigmatized populations. These could include requirements for enhanced education in medical schools and anti-oppression training for primary care practices.40,57,58 Finally, researchers should assess the effectiveness of these interventions and determine if they improve access to high-quality care.

Limitations

Our study had several limitations. First, as we were not able to determine if participants met our inclusion criteria until after making a phone call and stating the script, we excluded many participants after allocation. However, given that we did not give participants an option to opt of the study, but only excluded those who did not meet our prespecified criteria, our approach is unlikely to lead to selection bias. Furthermore, our analysis showed no statistical difference in reasons for exclusion between the two groups (eAppendix 2 in Supplement 2). Second, although physicians were our unit of analysis and are responsible for accepting new patients, it is possible that the reception staff are authorized to make these decisions. Third, we conducted our study during the COVID-19 pandemic, which may have led to low rates of new patient acceptance and contributed to nonsignificant findings for some of our secondary analyses.30,59,60 It is unclear how the pandemic might have affected acceptance rates of a patient with OUD vs diabetes. Finally, our findings may not be generalizable to other contexts outside of Ontario.

Conclusions

In this study, family physicians were less likely to offer a new patient appointment to a person with OUD than with diabetes. Our findings suggest that physician discretion in accepting new patients contributes to poor primary care access for people in this marginalized population. Policymakers and professional regulatory bodies should strengthen policies for accepting new patients, enhance medical training, ensure compensation reflects patient complexity, and require clinician anti-oppression training. They should also consider removing physician discretion in accepting new patients by using a geographic catchment area model. Universal health care coverage must be combined with policies that ensure equitable access to care.

Supplement 1.

Trial Protocol

Supplement 2.

eTable 1. Background Information for Clinical Caller

eTable 2. Responses to Questions

eTable 3. Voicemail

eAppendix 1. Physician Characteristics

eAppendix 2. Exclusions After Allocation

Supplement 3.

Data Sharing Statement

References

  • 1.Degenhardt L, Charlson F, Ferrari A, et al. ; GBD 2016 Alcohol and Drug Use Collaborators . The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987-1012. doi: 10.1016/S2215-0366(18)30337-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Anderson KE, Alexander GC, Niles L, Scholle SH, Saloner B, Dy SM. Quality of preventive and chronic illness care for insured adults with opioid use disorder. JAMA Netw Open. 2021;4(4):e214925. doi: 10.1001/jamanetworkopen.2021.4925 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wu LT, Zhu H, Ghitza UE. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: results from electronic health records data. Drug Alcohol Depend. 2018;192:316-323. doi: 10.1016/j.drugalcdep.2018.08.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Piske M, Zhou H, Min JE, et al. The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada. Addiction. 2020;115(8):1482-1493. doi: 10.1111/add.14947 [DOI] [PubMed] [Google Scholar]
  • 5.Oliva EM, Harris AHS, Trafton JA, Gordon AJ. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors. Drug Alcohol Depend. 2012;122(3):241-246. doi: 10.1016/j.drugalcdep.2011.10.004 [DOI] [PubMed] [Google Scholar]
  • 6.Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. Opioid agonist therapy during hospitalization within the Veterans Health Administration: a pragmatic retrospective cohort analysis. J Gen Intern Med. 2020;35(8):2365-2374. doi: 10.1007/s11606-020-05815-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q. 2005;83(3):457-502. doi: 10.1111/j.1468-0009.2005.00409.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Shi L. The impact of primary care: a focused review. Scientifica (Cairo). 2012;2012:432892. doi: 10.6064/2012/432892 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kiran T, Kopp A, Glazier RH. Those left behind from voluntary medical home reforms in Ontario, Canada. Ann Fam Med. 2016;14(6):517-525. doi: 10.1370/afm.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kim TW, Samet JH, Cheng DM, Winter MR, Safran DG, Saitz R. Primary care quality and addiction severity: a prospective cohort study. Health Serv Res. 2007;42(2):755-772. doi: 10.1111/j.1475-6773.2006.00630.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Spithoff S, Kiran T, Khuu W, et al. Quality of primary care among individuals receiving treatment for opioid use disorder. Can Fam Physician. 2019;65(5):343-351. [PMC free article] [PubMed] [Google Scholar]
  • 12.Haddad MS, Zelenev A, Altice FL. Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers. J Urban Health. 2015;92(1):193-213. doi: 10.1007/s11524-014-9924-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kendall CE, Boucher LM, Donelle J, et al. Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada. BMC Health Serv Res. 2020;20(1):837. doi: 10.1186/s12913-020-05670-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Benjamin-Johnson R, Moore A, Gilmore J, Watkins K. Access to medical care, use of preventive services, and chronic conditions among adults in substance abuse treatment. Psychiatr Serv. 2009;60(12):1676-1679. doi: 10.1176/ps.2009.60.12.1676 [DOI] [PubMed] [Google Scholar]
  • 15.Rajaratnam R, Sivesind D, Todman M, Roane D, Seewald R. The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life. J Opioid Manag. 2009;5(1):27-37. doi: 10.5055/jom.2009.0004 [DOI] [PubMed] [Google Scholar]
  • 16.Gomes T, Campbell TJ, Martins D, et al. Inequities in access to primary care among opioid recipients in Ontario, Canada: a population-based cohort study. PLoS Med. 2021;18(6):e1003631. doi: 10.1371/journal.pmed.1003631 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ross LE, Vigod S, Wishart J, et al. Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study. BMC Fam Pract. 2015;16:135. doi: 10.1186/s12875-015-0353-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lavie-Ajayi M, Moran GS, Levav I, et al. Using the capabilities approach to understand inequality in primary health-care services for people with severe mental illness. Isr J Health Policy Res. 2018;7(1):49. doi: 10.1186/s13584-018-0236-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Melamed OC, Fernando I, Soklaridis S, Hahn MK, LeMessurier KW, Taylor VH. Understanding engagement with a physical health service: a qualitative study of patients with severe mental illness. Can J Psychiatry. 2019;64(12):872-880. doi: 10.1177/0706743719862980 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chaar BB, Wang H, Day CA, Hanrahan JR, Winstock AR, Fois R. Factors influencing pharmacy services in opioid substitution treatment. Drug Alcohol Rev. 2013;32(4):426-434. doi: 10.1111/dar.12032 [DOI] [PubMed] [Google Scholar]
  • 21.Becker WC, Fiellin DA. Provider satisfaction with office-based treatment of opioid dependence: a systematic review. Subst Abus. 2005;26(1):15-22. doi: 10.1300/J465v26n01_02 [DOI] [PubMed] [Google Scholar]
  • 22.Brar R, Milloy MJ, DeBeck K, et al. Inability to access primary care clinics among people who inject drugs in a Canadian health care setting. Can Fam Physician. 2021;67(12):e348-e354. doi: 10.46747/cfp.6712e348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Crooks VA, Agarwal G, Harrison A. Chronically ill Canadians’ experiences of being unattached to a family doctor: a qualitative study of marginalized patients in British Columbia. BMC Fam Pract. 2012;13:69. doi: 10.1186/1471-2296-13-69 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gunner E, Chandan SK, Marwick S, et al. Provision and accessibility of primary healthcare services for people who are homeless: a qualitative study of patient perspectives in the UK. Br J Gen Pract. 2019;69(685):e526-e536. doi: 10.3399/bjgp19X704633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Rosser WW, Colwill JM, Kasperski J, Wilson L. Progress of Ontario’s Family Health Team model: a patient-centered medical home. Ann Fam Med. 2011;9(2):165-171. doi: 10.1370/afm.1228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Statistics Canada . Population estimates, quarterly. Revised June 22, 2022. Accessed July 11, 2022. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000901
  • 27.Martin D, Miller AP, Quesnel-Vallée A, Caron NR, Vissandjée B, Marchildon GP. Canada’s universal health-care system: achieving its potential. Lancet. 2018;391(10131):1718-1735. doi: 10.1016/S0140-6736(18)30181-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Statistics Canada . Primary health care providers, 2019. October 22, 2020. Accessed February 15, 2022. https://www150.statcan.gc.ca/n1/pub/82-625-x/2020001/article/00004-eng.htm
  • 29.Kiran T, Kopp A, Moineddin R, Glazier RH. Longitudinal evaluation of physician payment reform and team-based care for chronic disease management and prevention. CMAJ. 2015;187(17):E494-E502. doi: 10.1503/cmaj.150579 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Olah ME, Gaisano G, Hwang SW. The effect of socioeconomic status on access to primary care: an audit study. CMAJ. 2013;185(6):E263-E269. doi: 10.1503/cmaj.121383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.College of Physicians and Surgeons of Ontario . Find a Doctor. Accessed January 25, 2019. https://www.cpso.on.ca/Public-Information-Services/Find-a-Doctor?search=general
  • 32.Statistics Canada . Population and dwelling counts: Canada and census subdivisions (municipalities) [Internet]. February 9, 2022. Accessed July 11, 2022. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=9810000201
  • 33.Fahmy N, Kouyoumdjian FG, Berkowitz J, et al. Access to primary care for persons recently released from prison. Ann Fam Med. 2018;16(6):549-551. doi: 10.1370/afm.2314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Marshall EG, Burge F, Gibson RJ, Lawson B, O’Connell C. Accepting new patients who require opioids into family practice: results from the MAAP-NS census survey study. BMC Fam Pract. 2019;20(1):141. doi: 10.1186/s12875-019-1027-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lagisetty PA, Healy N, Garpestad C, Jannausch M, Tipirneni R, Bohnert ASB. Access to primary care clinics for patients with chronic pain receiving opioids. JAMA Netw Open. 2019;2(7):e196928. doi: 10.1001/jamanetworkopen.2019.6928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the “narc” cabinet. J Gen Intern Med. 2002;17(5):327-333. doi: 10.1007/s11606-002-0034-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wenghofer EF, Wilson L, Kahan M, et al. Survey of Ontario primary care physicians’ experiences with opioid prescribing. Can Fam Physician. 2011;57(3):324-332. [PMC free article] [PubMed] [Google Scholar]
  • 38.Anstice S, Strike CJ, Brands B. Supervised methadone consumption: client issues and stigma. Subst Use Misuse. 2009;44(6):794-808. doi: 10.1080/10826080802483936 [DOI] [PubMed] [Google Scholar]
  • 39.Earnshaw V, Smith L, Copenhaver M. Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. Int J Ment Health Addict. 2013;11(1):110-122. doi: 10.1007/s11469-012-9402-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Urbanoski K, Pauly B, Inglis D, et al. Defining culturally safe primary care for people who use substances: a participatory concept mapping study. BMC Health Serv Res. 2020;20(1):1060. doi: 10.1186/s12913-020-05915-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Rao H, Mahadevappa H, Pillay P, Sessay M, Abraham A, Luty J. A study of stigmatized attitudes towards people with mental health problems among health professionals. J Psychiatr Ment Health Nurs. 2009;16(3):279-284. doi: 10.1111/j.1365-2850.2008.01369.x [DOI] [PubMed] [Google Scholar]
  • 42.Kennedy-Hendricks A, Busch SH, McGinty EE, et al. Primary care physicians’ perspectives on the prescription opioid epidemic. Drug Alcohol Depend. 2016;165(165):61-70. doi: 10.1016/j.drugalcdep.2016.05.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017;18(1):19. doi: 10.1186/s12910-017-0179-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Thavam T, Devlin RA, Thind A, Zaric GS, Sarma S. The impact of the diabetes management incentive on diabetes-related services: evidence from Ontario, Canada. Eur J Health Econ. 2020;21(9):1279-1293. doi: 10.1007/s10198-020-01216-6 [DOI] [PubMed] [Google Scholar]
  • 45.Guan Q, Khuu W, Spithoff S, et al. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014. Drug Alcohol Depend. 2017;177:315-321. doi: 10.1016/j.drugalcdep.2017.05.002 [DOI] [PubMed] [Google Scholar]
  • 46.Osborne G. The last United States election represents a paradigm shift in drug policy, says U of A Augustana professor. University of Alberta news release. March 12, 2021. Accessed October 22, 2021. https://www.ualberta.ca/augustana/news/2021/03/geraint-osborne-drug-policy.html
  • 47.Scottish Government . Public attitudes towards people with drug dependence and people in recovery—Research Findings. June 10, 2016. Accessed October 22, 2021. http://www.gov.scot/publications/public-attitudes-towards-people-drug-dependence-people-recovery-research-findings
  • 48.Gorfinkel L, Klimas J, Reel B, et al. In-hospital training in addiction medicine: a mixed-methods study of health care provider benefits and differences. Subst Abus. 2019;40(2):207-213. doi: 10.1080/08897077.2018.1561596 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Klimas J, Ahamad K, Fairgrieve C, et al. Impact of a brief addiction medicine training experience on knowledge self-assessment among medical learners. Subst Abus. 2017;38(2):141-144. doi: 10.1080/08897077.2017.1296055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Blake H, Leighton P, van der Walt G, Ravenscroft A. Prescribing opioid analgesics for chronic non-malignant pain in general practice—a survey of attitudes and practice. Br J Pain. 2015;9(4):225-232. doi: 10.1177/2049463715579284 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.McColl MA, Aiken A, Schaub M. Do people with disabilities have difficulty finding a family physician? Int J Environ Res Public Health. 2015;12(5):4638-4651. doi: 10.3390/ijerph120504638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Franklin GM, Fulton-Kehoe D, Turner JA, Sullivan MD, Wickizer TM. Changes in opioid prescribing for chronic pain in Washington State. J Am Board Fam Med. 2013;26(4):394-400. doi: 10.3122/jabfm.2013.04.120274 [DOI] [PubMed] [Google Scholar]
  • 53.Price D, Baker E. Patient Care Groups: A new model of population based primary health care for Ontario. Primary Health Care Expert Advisory Committee. Published May 2015. Accessed March 18, 2022. https://health.gov.on.ca/en/common/ministry/publications/reports/primary_care/primary_care_price_report.pdf
  • 54.College of Physicians and Surgeons on Ontario . Policy # 1-17 Accepting New Patients. Updated May 2017. Accessed January 28, 2019. https://www.cpso.on.ca/Physicians/Policies-Guidance/Policies/Accepting-New-Patients
  • 55.Smith V, Marshall EG. “Meet and greets” in family practice: who, why, and to what end? Can Fam Physician. 2021;67(8):e227-e234. doi: 10.46747/cfp.6708e227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bayoumi I, Schultz SE, Glazier RH. Primary care reform and funding equity for mental health disorders in Ontario: a retrospective observational population-based study. CMAJ Open. 2020;8(2):E455-E461. doi: 10.9778/cmajo.20190153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Chapman EN, Kaatz A, Carnes M. Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. J Gen Intern Med. 2013;28(11):1504-1510. doi: 10.1007/s11606-013-2441-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Alves PCG, Stevenson FA, Mylan S, Pires N, Winstock A, Ford C. How do people who use drugs experience treatment? a qualitative analysis of views about opioid substitution treatment in primary care (iCARE study). BMJ Open. 2021;11(2):e042865. doi: 10.1136/bmjopen-2020-042865 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Kiran T, Wang R, Handford C, et al. Keeping doors open: A cross-sectional survey of family physician practice patterns during COVID-19, needs, and intentions. medRxiv. Preprint posted December 21, 2021. doi: 10.1101/2021.12.20.21267918 [DOI]
  • 60.Kiran T, Green ME, Wu FC, et al. Did the COVID-19 pandemic result in more family physicians stopping practice? Results from Ontario, Canada. medRxiv. Preprint posted September 22, 2021. doi: 10.1101/2021.09.21.21263891 [DOI]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1.

Trial Protocol

Supplement 2.

eTable 1. Background Information for Clinical Caller

eTable 2. Responses to Questions

eTable 3. Voicemail

eAppendix 1. Physician Characteristics

eAppendix 2. Exclusions After Allocation

Supplement 3.

Data Sharing Statement


Articles from JAMA Network Open are provided here courtesy of American Medical Association

RESOURCES